<--- Back to Details
First PageDocument Content
Anticoagulants / Heparins / Direct thrombin inhibitors / Coagulation system / Rivaroxaban / Dabigatran / Apixaban / Warfarin / Venous thrombosis / Chemistry / Organic chemistry / Hematology
Date: 2014-04-28 19:30:18
Anticoagulants
Heparins
Direct thrombin inhibitors
Coagulation system
Rivaroxaban
Dabigatran
Apixaban
Warfarin
Venous thrombosis
Chemistry
Organic chemistry
Hematology

Cardiology David Brieger Jenny Curnow Anticoagulation: a GP

Add to Reading List

Source URL: www.racgp.org.au

Download Document from Source Website

File Size: 330,73 KB

Share Document on Facebook

Similar Documents

Blood / Medicine / Anatomy / Transfusion medicine / Hematology / Blood products / Coagulation system / Platelet / Blood transfusion / Hematocrit / Bleeding / Blood type

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Cell biology / Biology / Blood / Programmed cell death / Apoptosis / Coagulation system / Cell signaling / Induced stem cells / Caspase / Platelet / Thrombopoiesis / Angiogenesis

Microsoft Wordfile00

DocID: 1r9dZ - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Medicine / Coagulation system / Thrombin / Antibody / Syringe / Surgical suture / Draft:Professor Dr. S Tsakas II

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Finance / Money / Economy / Transfusion medicine / Blood products / Corporate finance / Venture capital / Coagulation system / Platelet / Nesta / Bleeding / Seed money

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document